Gastric secretion

Current Opinion in Gastroenterology

Volumn 22, Issue 6, 2006, Pages 593-598

  Hou, Wei ^a   Schubert, Mitchell L ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acid secretion; Enteric nervous system; Gastrin; Helicobacter pylori; Histamine; Parietal cell; Pepsinogen; Peptide

Indexed keywords

AMINO ACID; ATRIAL NATRIURETIC FACTOR; CELECOXIB; GASTRIN; GHRELIN; GLICENTIN; GLUCAGON LIKE PEPTIDE 1; LEPTIN; LEUCINE; NITRIC OXIDE; OREXIN; OREXIN A; OREXIN B; OXYNTOMODULIN; PEPSINOGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHENYLALANINE; TRYPTOPHAN;

GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERGASTRINEMIA; HYPERPLASIA; IMMUNOREACTIVITY; NONHUMAN; PEPTIC ULCER; PROTEIN EXPRESSION; REVIEW; STATISTICAL SIGNIFICANCE; STOMACH ACID; STOMACH ACID SECRETION; STOMACH BIOPSY; STOMACH FISTULA; STOMACH GLAND; STOMACH MUCOSA; STOMACH SECRETION;

ANIMALS; ENTERIC NERVOUS SYSTEM; GASTRIC ACID; GASTRINS; HUMANS; PARIETAL CELLS, GASTRIC; PEPSINOGENS; STOMACH;

EID: 33750334007     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mog.0000245538.43142.87     Document Type: Review

References (36)

1. Malfertheiner P, Fass R, Quigley EMM, et al. From gastrin to gastro-oesophageal reflux disease: a century of acid suppression. Aliment Pharmacol Ther 2006; 23:683-690.
2. Centanni M, Gargano L, Canettieri G, et al. Thyroxin in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 2006; 354:1787-1795.
3. Dial S, Delaney JAC, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005; 294:2989-2995. A population-based case-control study of 1672 cases of C. difficile recorded between 1994 and 2004 in the UK shows that use of proton pump inhibitors was associated with a threefold increased risk of community-acquired C. difficile.
4. Lundell L, Havu N, Miettinen P, et al. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Aliment Pharmacol Ther 2006; 23:639-647.
5. Hamilton MA, Chapman MV, Mutch M, et al. The relationship between a pentagastrin-stimulated gastric luminal acid production test (Gastrotest) and enteral feeding-related gastrointestinal complications in critically ill patients. Anesth Analg 2005; 100:1447-1452. Interesting study showing that an inadequate acid response to pentagastrin is associated with increased gastrointestinal complications in critically ill patients receiving enteral feeds.
6. Yuan PQ, Kimura H, Million M, et al. Central vagal stimulation activates enteric cholinergic neurons in the stomach and VIP neurons in the duodenum in conscious rats. Peptides 2005; 26:653-664.
7. Minowa S, Ishihara S, Tsuchiya S, et al. Capsaicin- and anandamide-induced gastric acid secretion via vanilloid receptor type 1 (TRPV1) in rat brain. Brain Res 2005; 1039:75-83.
8. Goetze JP, Hansen CP, Rehfeld JF. Antral content, secretion and peripheral metabolism of N-terminal progastrin fragments. Regulatory Peptides 2006; 133:47-53.
9. Kanda N, Seno H, Kawada M, et al. Involvement of cyclooxygenase-2 in gastric mucosal hypertrophy in gastrin transgenic mice. Am J Physiol Gastrointest Liver Physiol 2006; 290:G519-G527.
10. Zavros Y, Eaton KA, Kang WQ, et al. Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene 2005; 24:2354-2366. Chronic inflammation, independently of H. pylori or hypergastrinemia, can lead to gastric cancer.
11. Friis-Hansen L, Wierup N, Rehfeld JF, Sundler F. Antral G-cell in gastrin and gastrin-cholecystokinin knockout animals. Cell Tissue Res 2005; 321:141-146.
12. Martinsen TC, Bakke I, Chen D, et al. Ciprofibrate stimulates the gastrin-producing cell by acting luminally on antral PPAR-α. Am J Physiol Gastrointest Liver Physiol 2005; 289:G1052-G1060.
13. Dumesny C, Patel O, Lachal S, et al. Synthesis, expression and biological activity of the prohormone for gastrin releasing peptide (ProGRP). Endocrinology 2006; 147:502-509.
14. Brzozowski T, Konturek PC, Konturek SJ, et al. Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regulatory Peptides 2004; 120:39-51.
15. Levin F, Edholm T, Ehrström M, et al. Effect of peripherally administered ghrelin on gastric emptying and acid secretion in the rat. Regulatory Peptides 2005; 131:59-65.
16. Isomoto H, Ueno H, Saenko VA, et al. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am J Gastroenterol 2005; 100:1711-1720.
17. Osawa H, Nakazato M, Date Y, et al. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 2005; 90:10-16.
18. Zhang J, Ren P-G, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310:996-999. Identification of a novel peptide derived from the ghrelin gene.
19. Ehrström M, Gustafsson T, Finn A, et al. Inhibitory effect of exogenous orexin a on gastric emptying, plasma leptin, and the distribution of orexin and orexin receptors in the gut and pancreas in man. J Clin Endocrinol Metab 2005; 90:2370-2377.
20. Ehrström M, Levin F, Kirchgessner AL, et al. Stimulatory effect of endogenous orexin A on gastric emptying and acid secretion independent of gastrin. Regul Peptides 2005; 132:9-16.
21. Busque SM, Kerstetter JE, Geibel JP, Insogna K. L-Type amino acids stimulate gastric acid secretion by activation of the calcium-sensing receptor in parietal cells. Am J Physiol Gastrointest Liver Physiol 2005; 289:G664-G669.
22. Li C, Yang Z, Yin Z, et al. Relationship between atrial natriuretic peptide-immunoreactive cells and microvessels in rat gastric mucosa. Acta Pharmacol Sinica 2006; 27:205-211.
23. Gower WR Jr, Premaratne S, McCuen RW, et al. Gastric atrial natriuretic peptide regulates endocrine secretion in antrum and fundus of human and rat stomach. Am J Physiol Gastrointest Liver Physiol 2003; 284:G638-G645.
24. Cammisotto PG, Renaud C, Gingras D, et al. Endocrine and exocrine secretion of leptin by the gastric mucosa. J Histochem Cytochem 2005; 53:851-860.
25. Cammisotto PG, Gingras D, Renaud C, et al. Secretion of soluble leptin receptors by exocrine and endocrine cells of the gastric mucosa. Am J Physiol Gastrointest Liver Physiol 2006; 290:G242-G249.
26. Sinclear EM, Drucker DJ. Proglucagon-derived peptides: mechanisms of action and therapeutic potential. Physiology 2005; 20:357-365.
27. Meier JJ, Nauck MA, Pott A, et al. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology 2006; 130:44-54.
28. Guan X, Karpen HE, Stephens J, et al. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 2006; 130:150-164.
29. Larsen PJ, Holst JJ. Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter. Regul Peptides 2005; 128:97-107.
30. Berg A, Redéen S, Grenegård M, et al. Nitric oxide inhibits gastric acid secretion by increasing intraparietal cell levels of cGMP in isolated human gastric glands. Am J Physiol Gastrointest Liver Physiol 2005; 289:G1061-G1066.
31. El Omar EM. Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection. Gut 2006; 55:144-146.
32. Liu Y, Vosmaer GDC, Tytgat GNJ, et al. Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and nonassociated gastritis. J Clin Pathol 2005; 58:927-931.
33. +-ATPase expression.
34. Lopez-Diaz L, Hinkle KL, Jain RN, et al. Parietal cell hyperstimulation and autoimmune gastritis in cholera toxin transgenic mice. Am J Physiol Gastrointest Liver Physiol 2006; 290:G970-G979.
35. Di Mario F, Ingegnoli A, Altavilla N, et al. Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels. Fundam Clin Pharmacol 2005; 19:497-501.
36. 3 muscarinic receptors. Am J Physiol Gastrointest Liver Physiol 2005; 289:G521-G529.